Association between White Blood Cells Count and Diabetes Mellitus in Tabari Cohort Study: A Case‑Control Study

Motahareh Kheradmand, Hossein Ranjbaran, Reza Alizadeh‑Navaei, Reza Yakhkeshi, Mahmood Moosazadeh


Background: White Blood Cells (WBC) can be a useful marker to predict diabetes. In this study, we aimed to investigate the association between WBC count with type 2 diabetes in a large‑scaled population‑based cohort study. Methods: In the present study we used a subset of data collected in enrolment phase of Tabari cohort study. Participants with fasting blood glucose ≥126 or those who report as having diabetes or taking glucose‑lowering medications were selected as case group (1765 participants) and control group included participants who did not report as having diabetes (1765 participants) and they randomly selected from the baseline population. Hematology indices were measured for all participants using Celltac Alpha MEK‑6510 K. Chi‑squared and independent t‑test were used to compare categorical and continuous variables, respectively. Results: The mean of WBC in diabetic patients and control group was 6.89 ± 1.67 and 6.37 ± 1.49 respectively (P ≤ 0.001). The odds of diabetes based on WBC count in crud model was 1.23 [CI 95% 1.181.28] and after adjustment for all possible confounding factor was 1.17 [CI 95% 1.111.23]. Conclusions: Results of the present study showed a significant association between WBC count and diabetes. This association remained significant after adjustment for all possible confounders.


Cohort study; diabetes mellitus; leukocyte count

Full Text:



Maffi P, Secchi A. The Burden of diabetes: Emerging data. Dev

Ophthalmol 2017;60:1‑5.

Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet


Lontchi‑Yimagou E, Sobngwi E, Matsha TE, Kengne AP.

Diabetes mellitus and inflammation. Curr Diabetes Rep


Boucher AA, Edeoga C, Ebenibo S, Wan J, Dagogo‑Jack S.

Leukocyte count and cardiometabolic risk among healthy

participants with parental type 2 diabetes: The Pathobiology of

Prediabetes in a Biracial Cohort study. Ethn Dis 2012;22:445‑50.

Hezaveh ZS, Feizy Z, Dehghani F, Sarbakhsh P, Moini A,

Vafa M. The association between maternal dietary protein

intake and risk of gestational diabetes mellitus. Int J Prev Med


Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B,

et al. White blood cells count and incidence of type 2 diabetes in

young men. Diabetes Care 2013;36:276‑82.

Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B,

et al. White blood cell count and the risk for coronary artery

disease in young adults. PloS One 2012;7:e47183.

Kheradmand M, Niimura H, Kuwabara K, Nakahata N,

Nakamura A, Ogawa S, et al. Association of inflammatory

gene polymorphisms and conventional risk factors with arterial

stiffness by age. J Epidemiol 2013;23:457‑65.

Qu D, Liu J, Lau CW, Huang Y. IL‑6 in diabetes

and cardiovascular complications. Br J Pharmacol


Oda E. High‑sensitivity C‑reactive protein, but not white

blood cell count, independently predicted incident diabetes

in a Japanese health screening population. Acta Diabetol


Du X, Zhu B, Hu G, Mao W, Wang S, Zhang H, et al. U‑shape

association between white blood cell count and the risk of

diabetes in young Chinese adults. Diab Med 2009;26:955‑60.

Kashima S, Inoue K, Matsumoto M, Akimoto K. White blood

cell count and c‑reactive protein independently predicted incident

diabetes: Yuport medical checkup center study. Endocr Res


Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence

of diabetes: Estimates for the year 2000 and projections for

Diabetes Care 2004;27:1047‑53.

El Ouahabi H, Doubi S, Boujraf S, Ajdi F. Gestational diabetes

and risk of developing postpartum Type 2 diabetes: How to

improve follow‑up? Int J Prev Med 2019;10:51.

Kheradmand M, Moosazadeh M, Saeedi M, Poustchi H,

Eghtesad S, Esmaeili R, et al. Tabari cohort profile and

preliminary results in urban areas and mountainous regions of

Mazandaran, Iran. Arch Iranian Med 2019;22:279‑85.

Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E,

Joukar F, Hamzeh B, et al. The PERSIAN Cohort: Providing

the evidence needed for healthcare reform. Arch Iranian Med


Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA,

Hekmatdoost A, et al. Prospective epidemiological research

studies in Iran (the PERSIAN Cohort Study): Rationale,

objectives, and design. Am J Epidemiol 2018;187:647‑55.

Center for disease control. National health and nutrition

examination survey (NHANES) anthropometry procedure


manual_an.pdf. Available from

nhanes/nhanes_07_08/manual_an.pdf. [Last accessed on 2020

Sep 20].

Tahir SAA. Total count and absolute values of white blood cell

in patients with diabetes mellitus type 2: Sudan University of

Science and Technology; 2015.

Zhang H, Yang Z, Zhang W, Niu Y, Li X, Qin L, et al. White

blood cell subtypes and risk of type 2 diabetes. J Diabetes

Complications 2017;31:31‑7.

Ford ES. Leukocyte count, erythrocyte sedimentation rate, and

diabetes incidence in a national sample of US adults. Am J

Epidemiol 2002;155:57‑64.

Mahdiani A, Kheirandish M, Bonakdaran S. Correlation between

white blood cell count and insulin resistance in Type 2 diabetes.

Curr Diabetes Rev 2019;15:62‑6.